Multiparametric approach using a simple triplex NASBA assay for hormone receptors and HER-2 status in breast cancer tumors.

被引：0
|
作者：
Verjat, T
Lamy, PJ
Servanton, AC
Leissner, P
Grenier, J
Mougin, B
机构：
[1] BioMerieux, Marcy Letoile, France
[2] Ctr Reg Lutte Canc Val DAurelle, Montpellier, France
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S197 / S197
页数：1
相关论文
共 50 条
  • [21] Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature
    Arslan, Cagatay
    Sari, Ebru
    Aksoy, Sercan
    Altundag, Kadri
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (01) : 21 - 30
  • [22] Predictive value of HER-2/neu gene status of breast cancer by immunohistochemstry: A survey of 700 tumors
    Yaziji, H
    Goldstein, L
    Werling, RW
    Wirtala, J
    Davie, P
    Gown, AM
    LABORATORY INVESTIGATION, 2002, 82 (01) : 57A - 58A
  • [23] Predictive value of HER-2/neu gene status of breast cancer by immunohistochemstry: A survey of 700 tumors
    Yaziji, H
    Goldstein, L
    Werling, RW
    Wirtala, J
    Davie, P
    Gown, AM
    MODERN PATHOLOGY, 2002, 15 (01) : 57A - 58A
  • [24] Utility of Serum HER-2/ neu in Prediction of Tissue HER-2 /neu Status of Primary Breast Cancer
    Mokhtari, Maral
    Khosravi, Mohammad Hadi
    MIDDLE EAST JOURNAL OF CANCER, 2021, 12 (04) : 483 - 490
  • [25] DISCORDANCE BETWEEN HORMONE RECEPTORS AND HER2 STATUS IN BREAST CANCER PATIENTS RELAPSE
    Roque, Katia
    Otoya, Iris
    Valdivieso, Natalia
    Morante, Zaida
    Fuentes, Hugo
    Neciosup, Silvia
    Gomez, Henry
    Cotito, Jorge
    Ziegler, Gonzalo
    Pena, Estefania
    Vidaurre, Tatiana
    de Mello, Ramon Andrade
    Castaneda, Carlos
    CANCER RESEARCH, 2024, 84 (09)
  • [26] HER-2 status determination in breast carcinomas.: A practical approach
    García-Caballero, T
    Menéndez, MD
    Vázquez-Boquete, A
    Gallego, R
    Forteza, J
    Fraga, M
    HISTOLOGY AND HISTOPATHOLOGY, 2006, 21 (03) : 227 - 236
  • [27] Quantitative association between, HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer
    Konecny, G
    Pauletti, G
    Pegram, M
    Untch, M
    Dandekar, S
    Aguilar, Z
    Wilson, C
    Rong, HM
    Bauerfeind, I
    Felber, M
    Wang, HJ
    Beryt, M
    Seshadri, R
    Hepp, H
    Slamon, DJ
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (02) : 142 - 153
  • [28] Prevalence of HER-2 and Hormone Receptors and P53 Mutations in the Pathologic Specimens of Breast Cancer Patients
    Mirmalek, Seyed Abbas
    Hajilou, Maryam
    Tabatabaee, Seyed Alireza Salimi
    Parsa, Yekta
    Yadollah-Damavandi, Soheila
    Parsa, Tina
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2014, 2014
  • [29] Comparative assays for the HER-2/neu oncogene status in breast cancer
    Vera-Román, JM
    Rubio-Martínez, LA
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2004, 128 (06) : 627 - 633
  • [30] Prognostic significance of HER-2 status in women with inflammatory breast cancer
    Dawood, Shaheenah
    Broglio, Kristine
    Gong, Yun
    Yang, Wei-Tse
    Cristofanilli, Massimo
    Kau, Shu-Wan
    Meric-BernstaM, Funda
    Buchholz, Thomas A.
    Hortobagyi, Gabriel N.
    Gonzalez-Angulo, Ana M.
    CANCER, 2008, 112 (09) : 1905 - 1911
12345